No Data
No Data
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating, Cuts Target Price to $8
Craig-Hallum analyst Matt Hewitt maintains $InfuSystems(INFU.US)$ with a buy rating, and adjusts the target price from $15 to $8.According to TipRanks data, the analyst has a success rate of 42.2%
Sanara MedTech, InfuSystem Joint Venture to Distribute ChemoMouthpiece Kits
Express News | Sanara Medtech Inc - Si Technologies to Distribute Chemomouthpiece’s Kits to 3,000 Cancer Centers
Express News | Sanara Medtech Inc - Draws $15.5 Million on Term Loan With Crg Servicing
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement With, and Minority Investment In, ChemoMouthpiece, LLC
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement With ChemoMouthpiece, LLC